When the system narrows the legitimate path, demand doesn't disappear. It just moves somewhere nobody can track it.
The FDA restricted 19 peptides in September 2023. One month later, tirzepatide was approved for weight loss. A physician who has been using these compounds for 20 years explains what actually happened.